| June 2004 | ||||||
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
| 1 | 2 | 3 | 4 | 5 | ||
| 6 | 7 | 8 | 9 | 10 | 11 | 12 |
| 13 | 14 | 15 | 16 | 17 | 18 | 19 |
| 20 | 21 | 22 | 23 | 24 | 25 | 26 |
| 27 | 28 | 29 | 30 | |||
| May Jul | ||||||
-------------------------------------------
http://www.worldnetdaily.com/news/article.asp?ARTICLE_ID=39078
LIFE WITH BIG BROTHER
Bush to screen population for mental illness
Sweeping initiative links diagnoses to treatment with specific drugs
Posted: June 21, 2004
5:00 p.m. Eastern
2004 WorldNetDaily.com
President Bush plans to unveil next month a sweeping mental
health initiative that recommends screening for every
citizen and promotes the use of expensive antidepressants
and antipsychotic drugs favored by supporters of the
administration.
The New Freedom Initiative, according to a progress report,
seeks to integrate mentally ill patients fully into the
community by providing "services in the community, rather
than institutions," the British Medical Journal reported.
Critics say the plan protects the profits of drug companies
at the expense of the public.
The initiative began with Bush's launch in April 2002 of the
New Freedom Commission on Mental Health, which conducted a
"comprehensive study of the United States mental health
service delivery system."
The panel found that "despite their prevalence, mental
disorders often go undiagnosed" and recommended
comprehensive mental health screening for "consumers of all
ages," including preschool children.
The commission said, "Each year, young children are expelled
from preschools and childcare facilities for severely
disruptive behaviors and emotional disorders."
Schools, the panel concluded, are in a "key position" to
screen the 52 million students and 6 million adults who work
at the schools.
The commission recommended that the screening be linked with
"treatment and supports," including "state-of-the-art
treatments" using "specific medications for specific
conditions."
The Texas Medication Algorithm Project, or TMAP, was held up
by the panel as a "model" medication treatment plan that
"illustrates an evidence-based practice that results in
better consumer outcomes."
The TMAP -- started in 1995 as an alliance of individuals
from the pharmaceutical industry, the University of Texas
and the mental health and corrections systems of Texas --
also was praised by the American Psychiatric Association,
which called for increased funding to implement the overall
plan.
But the Texas project sparked controversy when a
Pennsylvania government employee revealed state officials
with influence over the plan had received money and perks
from drug companies who stand to gain from it.
Allen Jones, an employee of the Pennsylvania Office of the
Inspector General says in his whistleblower report the
"political/pharmaceutical alliance" that developed the Texas
project, which promotes the use of newer, more expensive
antidepressants and antipsychotic drugs, was behind the
recommendations of the New Freedom Commission, which were
"poised to consolidate the TMAP effort into a comprehensive
national policy to treat mental illness with expensive,
patented medications of questionable benefit and deadly side
effects, and to force private insurers to pick up more of
the tab."
Jones points out, according to the British Medical Journal,
companies that helped start the Texas project are major
contributors to Bush's election funds. Also, some members of
the New Freedom Commission have served on advisory boards
for these same companies, while others have direct ties to
TMAP.
Eli Lilly, manufacturer of olanzapine, one of the drugs
recommended in the plan, has multiple ties to the Bush
administration, BMJ says. The elder President Bush was a
member of Lilly's board of directors and President Bush
appointed Lilly's chief executive officer, Sidney Taurel, to
the Homeland Security Council.
Of Lilly's $1.6 million in political contributions in 2000,
82 percent went to Bush and the Republican Party.
Another critic, Robert Whitaker, journalist and author of
"Mad in America," told the British Medical Journal that
while increased screening "may seem defensible," it could
also be seen as "fishing for customers."
Exorbitant spending on new drugs "robs from other forms of
care such as job training and shelter program," he said.
However, a developer of the Texas project, Dr. Graham
Emslie, defends screening.
"There are good data showing that if you identify kids at an
earlier age who are aggressive, you can intervene ... and
change their trajectory."
9:06:18 AM